Myrtelleincis A Gene Therapy Company Based In New Yorkdedicated To Developing Innovative Treatments For Neurodegenerative Diseasesthe Company Focuses On Myelin Based Diseasesparticularly White Matter Disorders Like Leukodystrophiesmyrtelle Emphasizes Scientific And Medical Advancements In Its Approach To Gene Therapy The Company Has A Strong Pipeline Of Gene Therapy Programs That Utilize Proprietary Technologies And Vectorsone Of Its Key Candidates Is Raav Olig001 Aspaaimed At Treating Canavan Diseasethis Candidate Is Part Of The Fda S Support For Clinical Trials Advancing Rare Disease Therapeuticsstartpilot Program And Has Received The Regenerative Medicine Advanced Therapyrmatdesignationmyrtelle Collaborates With Pfizer Incfor Its Canavan Disease Program And Works With Raaven Therapeutics To Develop Novel Gene Therapy Vectors Myrtelle S Proprietary Platform And Intellectual Property Support Its Mission To Advance Gene Therapy For Neurodegenerative Diseasesensuring It Retains Exclusive Rights To Commercialize Its Innovations
No conferences found for this company.
| Company Name | Myrtelle Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
